Mutated EGFR-IN-1

1421372-66-8

Osimertinib analog

12352005

H302, H315, H319, H335

EGFR

Reference compound

JAK/STAT Signaling; Protein Tyrosine Kinase/RTK

Cancer-Kinase/protease

Cancer

https://www.medchemexpress.com/mutated-egfr-in-1.html

10mM

99.90

DMSO : ≥ 75 mg/mL

NC1=CC(NC2=NC=CC(C3=CN(C)C4=C3C=CC=C4)=N2)=C(OC)C=C1N(CCN(C)C)C

C25H31N7O

445.56

H302, H315, H319, H335

[1]Patent WO 2013014448 A1. 2 - (2, 4, 5 - substituted -anilino) pyrimidine derivatives as egfr modulators useful for treating cancer
 .

Room Temperature

-20°C, 3 years; 4°C, 2 years (Powder)

Reference compound1

No Development Reported